Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma

Author(s):
Nissen, L.H.C.; Pierik, M.; Derikx, L.A.A.P.; Jong, E. de; Kievit, W.; Heuvel, T.R.A. van den; Rosendael, A.R. van; Plasmeijer, E.I.; Dewint, P.; Verhoeven, R.H.A.; Overbeek, L.I.H.; Nagtegaal, I.D.; Hoentjen, F.; Meulen-de Jong, A.E. van der; Dutch Initiative Crohn & Colitis; PALGA Grp; IBD & Melanoma Grp
Published
2017
Publication type
Article / Letter to editor
inflammatory bowel diseasesmelanomaimmunosuppressive therapy
Date issued
2017-11-30
Language
English
Is part of
Inflammatory Bowel Diseases (2017), Vol. 23, no. 11, p. 2018-2026
hdl
1887/117534
doi
10.1097/MIB.0000000000001191